SCHEMBL23909892

SCHEMBL23909892

C[C@@H](c1ccccc1)N1CCNC1=O

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.50
KMT2A Q03164 1/20 0.45
HSD11B1 P28845 2/20 0.44
MC4R P32245 1/20 0.44
ALDH1A1 P00352 4/20 0.43
POLB P06746 1/20 0.43
OPRM1 P35372 1/20 0.43
OPRD1 P41143 1/20 0.43
OPRK1 P41145 1/20 0.43
OPRL1 P41146 1/20 0.43
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
HPGD P15428 1/20 0.41
RET P07949 1/20 0.40
KDR P35968 1/20 0.40
MAPK1 P28482 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23909932 1.00 CYP2D6 (0.50) CYP2D6KMT2AHSD11B1MC4RALDH1A1
SCHEMBL11835191 1.00 CYP2D6 (0.50) CYP2D6KMT2AHSD11B1MC4RALDH1A1
SCHEMBL7267508 0.81 RET (0.42) CYP2D6KMT2AALDH1A1POLBOPRD1
SCHEMBL5563143 0.81 KMT2A (0.48) CYP2D6KMT2AALDH1A1OPRM1OPRD1
Bromide SCHEMBL31141425 0.79 CYP2D6 (0.47) CYP2D6KMT2AHSD11B1MC4RALDH1A1
SCHEMBL8401531 0.78 CYP2D6 (0.46) CYP2D6KMT2AHSD11B1MC4RALDH1A1
SCHEMBL16915160 0.78 RET (0.38) CYP2D6KMT2AALDH1A1POLBOPRD1
SCHEMBL6632844 0.78 RET (0.38) CYP2D6KMT2AALDH1A1POLBOPRD1
SCHEMBL16915011 0.75 RET (0.38) CYP2D6KMT2AALDH1A1POLBRET
SCHEMBL2397094 0.73 HSD11B1 (0.46) HSD11B1OPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240158415-A1 AMINOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL INC (US) 2024-05-16 US disclosed
US-11667651-B2 Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2023-06-06 US disclosed
US-11667651-B2 Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2023-06-06 US disclosed
US-11667651-B2 Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors HIBERCELL, INC. (US) 2023-06-06 US disclosed
US-20210317136-A1 AMINOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2021-10-14 US disclosed
US-20210317136-A1 AMINOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS HIBERCELL, INC. 2021-10-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158415-A1 AMINOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1B, PIP5K1A, PIP5K1C CYP2D6 2324/4885KMT2A 1842/4885HSD11B1 4366/4885
US-11667651-B2 Aminopyridine derivatives as phosphatidylinositol phosphate kinase inhibitors PIP5K1B, PIP5K1A, PIP5K1C CYP2D6 2167/4885KMT2A 2202/4885HSD11B1 4405/4885
US-20210317136-A1 AMINOPYRIDINE DERIVATIVES AS PHOSPHATIDYLINOSITOL PHOSPHATE KINASE INHIBITORS PIP5K1B, PIP5K1A, PIP5K1C CYP2D6 2167/4885KMT2A 2202/4885HSD11B1 4405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.